FTNT:NASDAQFortinet, Inc. Analysis
Data as of 2026-03-10 - not real-time
$83.81
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Fortinet is trading at $83.81, just above its 20‑day SMA of $81.73 and 50‑day SMA of $80.36, indicating modest upside momentum. The MACD line sits at +0.50 well above the signal, producing a bullish histogram, while the RSI of 57 suggests the stock is neither overbought nor oversold. Price action remains confined between a solid support at $74.31 and resistance near $88.60, with the current level only $5 below the nearest resistance. Volatility is elevated at roughly 39% over the past 30 days and beta of 1.2, reflecting higher sensitivity to market swings. Fundamental metrics show 14.8% YoY revenue growth, an impressive 80% gross margin and 32% operating margin, underscoring strong profitability. However, the DCF‑derived fair value of $63.7 is well below the market price, implying the stock is priced at a ~6% premium to its intrinsic estimate. The company carries $1.06 bn of debt against $3.58 bn of cash, yielding a low net leverage, but a debt‑to‑equity of 86% flags balance‑sheet caution. Recent analyst coverage downgraded Fortinet to “hold” amid margin‑pressure concerns and an 8% price dip following the 2026 guidance release.
Despite the short‑term valuation stretch, Fortinet’s AI‑driven security platform and 40% billings growth in its Unified SaaS segment point to durable top‑line expansion. The “Extreme Greed” reading on the Fear & Greed Index (75.9) suggests market enthusiasm, but the neutral technical trend and decreasing volume temper optimism. Overall, the blend of robust cash generation, high recurring revenue and a favorable industry PE relative to peers supports a longer‑run buying case. Investors should weigh the elevated volatility and valuation premium against the company’s growth trajectory when timing entry.
Despite the short‑term valuation stretch, Fortinet’s AI‑driven security platform and 40% billings growth in its Unified SaaS segment point to durable top‑line expansion. The “Extreme Greed” reading on the Fear & Greed Index (75.9) suggests market enthusiasm, but the neutral technical trend and decreasing volume temper optimism. Overall, the blend of robust cash generation, high recurring revenue and a favorable industry PE relative to peers supports a longer‑run buying case. Investors should weigh the elevated volatility and valuation premium against the company’s growth trajectory when timing entry.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Recent downgrade to hold and margin pressure
- Bullish MACD but high volatility
- Proximity to support level provides downside cushion
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- 15% revenue growth and strong gross margins
- Expanding AI and SaaS billings
- Strong cash position offsets modest leverage
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Long‑term cybersecurity spend growth
- High recurring SaaS revenue and low churn
- Strategic product integration across network and security
Key Metrics & Analysis
Financial Health
Revenue Growth14.80%
Profit Margin27.26%
P/E Ratio34.6
ROE135.72%
ROA12.87%
Debt/Equity85.80
P/B Ratio50.3
Op. Cash Flow$2.6B
Free Cash Flow$1.7B
Industry P/E36.8
Technical Analysis
TrendNeutral
RSI57.0
Support$74.31
Resistance$88.60
MA 20$81.73
MA 50$80.36
MA 200$87.05
MACDBullish
VolumeDecreasing
Fear & Greed Index75.89
Valuation
Fair Value$63.69
Target Price$89.06
Upside/Downside6.26%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta1.20
Volatility39.25%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.